Month: November 2020

Jaguar Health Announces Plan to Develop and Commercialize Crofelemer, the Company’s Novel Proprietary Drug, for the Indication of Inflammatory Diarrhea, Initially in ‘Long-Hauler’ COVID-19 Recovery Patients

A significant percentage of COVID-19 recovery patients suffer from long-term diarrhea or other gastrointestinal disfunctions Non-binding terms to fund activities...

error: Content is protected !!